Arcosa, Inc. (NYSE:ACA) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. reduced its stake in shares of Arcosa, Inc. (NYSE:ACAFree Report) by 0.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,171 shares of the company’s stock after selling 137 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Arcosa were worth $1,627,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. ProShare Advisors LLC increased its position in Arcosa by 6.1% during the first quarter. ProShare Advisors LLC now owns 11,875 shares of the company’s stock worth $1,020,000 after buying an additional 680 shares during the period. State Board of Administration of Florida Retirement System raised its position in Arcosa by 25.7% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 17,412 shares of the company’s stock valued at $1,495,000 after purchasing an additional 3,560 shares during the last quarter. Covestor Ltd boosted its stake in Arcosa by 38.8% during the 1st quarter. Covestor Ltd now owns 888 shares of the company’s stock worth $77,000 after purchasing an additional 248 shares during the period. UniSuper Management Pty Ltd purchased a new position in Arcosa during the 1st quarter worth $754,000. Finally, CANADA LIFE ASSURANCE Co increased its stake in Arcosa by 8.0% in the first quarter. CANADA LIFE ASSURANCE Co now owns 43,275 shares of the company’s stock valued at $3,712,000 after purchasing an additional 3,202 shares during the period. 90.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on ACA shares. Oppenheimer raised their price target on Arcosa from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Monday, August 19th. Barclays started coverage on Arcosa in a report on Tuesday, October 29th. They issued an “overweight” rating and a $106.00 target price on the stock. Finally, Stephens raised Arcosa from an “equal weight” rating to an “overweight” rating and set a $96.00 price target for the company in a report on Wednesday, August 7th.

View Our Latest Stock Report on Arcosa

Arcosa Price Performance

Shares of ACA opened at $101.39 on Monday. The firm has a market capitalization of $4.95 billion, a PE ratio of 38.55 and a beta of 0.71. The stock’s 50 day moving average is $94.70 and its two-hundred day moving average is $88.95. Arcosa, Inc. has a twelve month low of $71.89 and a twelve month high of $107.79. The company has a current ratio of 3.61, a quick ratio of 2.77 and a debt-to-equity ratio of 0.51.

Arcosa (NYSE:ACAGet Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.13. Arcosa had a return on equity of 6.64% and a net margin of 5.17%. The firm had revenue of $640.40 million for the quarter, compared to analyst estimates of $682.52 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. Arcosa’s quarterly revenue was up 8.2% on a year-over-year basis. Research analysts anticipate that Arcosa, Inc. will post 3.38 earnings per share for the current year.

Arcosa Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Tuesday, October 15th were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.20%. The ex-dividend date was Tuesday, October 15th. Arcosa’s dividend payout ratio is currently 7.60%.

Insiders Place Their Bets

In other news, Director Steven J. Demetriou bought 6,000 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were bought at an average cost of $87.70 per share, for a total transaction of $526,200.00. Following the completion of the transaction, the director now owns 9,943 shares in the company, valued at $872,001.10. This trade represents a 152.17 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Arcosa Company Profile

(Free Report)

Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.

Read More

Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACAFree Report).

Institutional Ownership by Quarter for Arcosa (NYSE:ACA)

Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.